Comparison of 22-gauge standard and Franseen needles in EUS-guided tissue acquisition for diagnosing solid pancreatic lesions: a multicenter randomized controlled trial

医学 随机对照试验 诊断准确性 临床终点 恶性肿瘤 不利影响 实体瘤疗效评价标准 放射科 核医学 外科 内科学 临床试验 临床研究阶段
作者
Masahiro Itonaga,Satoru Yasukawa,Nobuyasu Fukutake,Takeshi Ogura,Masanori Asada,Toshio Shimokawa,Osamu Inatomi,Yoshitaka Nakai,Hideyuki Shiomi,Hiroko Nebiki,Azumi Suzuki,Koh Kitagawa,Satoshi Asai,Masaaki Shimatani,Tsuyoshi Sanuki,Akira Kurita,Mamoru Takenaka,Motoyuki Yoshida,Noriyuki Hoki,Hiroaki Yasuda,Hirotsugu Maruyama,Hisakazu Matsumoto,Akio Yanagisawa,Masayuki Kitano
出处
期刊:Gastrointestinal Endoscopy [Elsevier BV]
卷期号:96 (1): 57-66.e2 被引量:26
标识
DOI:10.1016/j.gie.2022.02.005
摘要

Background and Aims This large multicenter randomized controlled trial compared the diagnostic yields of 22-gauge standard and 22-gauge Franseen needles for EUS-guided tissue acquisition (EUS-TA) of solid pancreatic lesions. Methods Consecutive patients with solid pancreatic lesions were prospectively randomized to EUS-TA using standard or Franseen needles. Samples obtained with the first needle pass and with second and subsequent passes were evaluated separately. The primary endpoint was the rate of accuracy for diagnosis of malignancy. Other endpoints were technical success rate, sample cellularity, adverse events, diagnostic accuracy in patient subgroups, and the diagnostic accuracy and numbers of second and subsequent needle passes. Results Of 523 patients undergoing EUS-TA, 260 were randomized to using standard 22-gauge needles and 263 to 22-gauge Franseen needles. The technical success rate in each group was 99.6%, with similar adverse event rates in the standard (1.5%) and Franseen (.8%) needle groups. First-pass EUS-TA using the Franseen needle resulted in significantly greater diagnostic accuracy (84.0% vs 71.2%, P < .001) and sensitivity (82.4% vs 66.7%, P < .001) than first-pass EUS-TA using a standard needle and also resulted in superior diagnostic accuracy in patients requiring immunostaining. Second and subsequent EUS-TA using Franseen needles showed significantly greater accuracy (94.7% vs 90.0%, P = .049) and sensitivity (94.0% vs 88.6%, P = .047) and required fewer needle passes (1.81 vs 2.03, P = .008) than using standard needles. Conclusions EUS-TA with the Franseen needle is superior to EUS-TA with a standard needle with respect to diagnostic accuracy per pass, particularly in patients who require immunostaining, and number of passes when using macroscopic on-site evaluation. (Clinical trial registration numbers: UMIN000030634 and jRCTs052180062.) This large multicenter randomized controlled trial compared the diagnostic yields of 22-gauge standard and 22-gauge Franseen needles for EUS-guided tissue acquisition (EUS-TA) of solid pancreatic lesions. Consecutive patients with solid pancreatic lesions were prospectively randomized to EUS-TA using standard or Franseen needles. Samples obtained with the first needle pass and with second and subsequent passes were evaluated separately. The primary endpoint was the rate of accuracy for diagnosis of malignancy. Other endpoints were technical success rate, sample cellularity, adverse events, diagnostic accuracy in patient subgroups, and the diagnostic accuracy and numbers of second and subsequent needle passes. Of 523 patients undergoing EUS-TA, 260 were randomized to using standard 22-gauge needles and 263 to 22-gauge Franseen needles. The technical success rate in each group was 99.6%, with similar adverse event rates in the standard (1.5%) and Franseen (.8%) needle groups. First-pass EUS-TA using the Franseen needle resulted in significantly greater diagnostic accuracy (84.0% vs 71.2%, P < .001) and sensitivity (82.4% vs 66.7%, P < .001) than first-pass EUS-TA using a standard needle and also resulted in superior diagnostic accuracy in patients requiring immunostaining. Second and subsequent EUS-TA using Franseen needles showed significantly greater accuracy (94.7% vs 90.0%, P = .049) and sensitivity (94.0% vs 88.6%, P = .047) and required fewer needle passes (1.81 vs 2.03, P = .008) than using standard needles. EUS-TA with the Franseen needle is superior to EUS-TA with a standard needle with respect to diagnostic accuracy per pass, particularly in patients who require immunostaining, and number of passes when using macroscopic on-site evaluation. (Clinical trial registration numbers: UMIN000030634 and jRCTs052180062.)

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Double完成签到 ,获得积分10
刚刚
向向完成签到 ,获得积分10
刚刚
宁霸完成签到,获得积分10
1秒前
1秒前
海布里的风完成签到 ,获得积分10
1秒前
慕青的应助被张恒采纳,获得10
5秒前
鱼鱼完成签到 ,获得积分10
5秒前
温一完成签到 ,获得积分10
5秒前
条条123完成签到 ,获得积分10
5秒前
5秒前
李玥完成签到 ,获得积分10
6秒前
ddddd完成签到,获得积分10
8秒前
fbwg完成签到,获得积分10
8秒前
fffxj完成签到,获得积分10
9秒前
null的应助被aimme采纳,获得10
10秒前
任性星星完成签到 ,获得积分10
10秒前
慧海拾穗完成签到,获得积分10
11秒前
锈雀完成签到,获得积分10
11秒前
完美世界的应助被七月流火采纳,获得10
12秒前
YP完成签到,获得积分10
12秒前
空白完成签到,获得积分10
13秒前
合适惜筠完成签到,获得积分10
14秒前
LB完成签到 ,获得积分10
14秒前
谨慎纸飞机完成签到,获得积分10
14秒前
小喜完成签到,获得积分10
15秒前
Jam完成签到,获得积分10
16秒前
MangoPie完成签到 ,获得积分10
16秒前
17秒前
易槐完成签到 ,获得积分10
18秒前
TheSail完成签到,获得积分10
19秒前
21秒前
端庄小懒虫完成签到,获得积分10
21秒前
蚂蚁牙黑完成签到 ,获得积分10
21秒前
义气觅双完成签到,获得积分10
21秒前
amberzyc完成签到,获得积分0
21秒前
蓝天碧海小西服完成签到,获得积分0
22秒前
6S6完成签到,获得积分10
22秒前
落后的小伙完成签到,获得积分20
22秒前
123完成签到,获得积分10
22秒前
11完成签到 ,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173372
求助须知:如何正确求助?哪些是违规求助? 9565632
关于积分的说明 21780795
捐赠科研通 7767536
什么是DOI,文献DOI怎么找? 3431575
关于科研通互助平台的介绍 2555846
邀请新用户注册赠送积分活动 2476763